Join us for the 2025 Joslin International Symposium!
Save the date and find out more at https://t.co/ovObvbqCJC!
Registration is now open, and please consider submitting an abstract.
Right as #EASD2024 wraps up, our #preprint is now online and highlights the relevance of hepatic GCGR signaling in the superior weight loss efficacy of a dual GCGR/GLP1R agonist! #ETH#obesity
https://t.co/uoxjv4g4Jf
Studies in mice and humans implicate disordered serotonin metabolism in the pathophysiology of post bariatric surgery associated #hypoglycemia@jclinicalinvest https://t.co/yR9yQyrXm9 #insulin
Glad I got the opportunity to present our research on the early effects of survodutide on systemic and adipose tissue insulin sensitivity, at the EASD conference in Madrid, Spain. Special thanks to the ETH Zürich and Boehringer Ingelheim teams for their support!
Our new paper demonstrating that Axl receptor inhibition induces brown fat functionality and augments non-shivering thermogenesis, is published in Nature Communications! #nature#naturecommunications#WolfrumLab#obesity@NatureComms
https://t.co/ujJj1BvSiz
Based on envisioned augmentation of thermogenesis in white and brown adipose tissue, targeting the AXL receptor tyrosine kinase is proposed as a strategy to Rx #obesity@NatureComms@WolfrumLab https://t.co/G6jM9bA7Mo
Brown adipose tissue is thought to combat obesity by acting as a sink for excess nutrients.
In @NatMetabolism, @tsengyuhua & @SpiteLab find that BAT reduces liver inflammation by producing an anti-inflammatory lipid, MaR2.
📄: https://t.co/ZCmCdPRukh
https://t.co/GKU5sJ1ywG